免疫性血小板缺血和免疫球蛋白G4相关疾病之间是否存在相关性?
Dorela Lame1, Michelangelo Pianelli1, Erika Morsia1
1Universita Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
Journal of hematology
|September 9, 2024
概括
与免疫球蛋白G4相关的疾病 (IgG4-RD) 很少与免疫血小板缺血 (ITP) 同时发生. 这一案例突出了管理共存IgG4-RD和ITP的挑战,表明了潜在的联系和进一步研究的需要.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 血液学 血液学 血液学
背景情况:
- 免疫球蛋白G4相关疾病 (IgG4-RD) 是一种罕见的免疫媒介疾病.
- 初级免疫性血小板缺血 (ITP) 的特征是血小板数量较低.
- IgG4-RD 和 ITP 的共存是不常见的.
研究的目的:
- 介绍一个患有同时存在IgG4-RD和ITP的病人的病例.
- 讨论管理挑战和治疗反应.
- 探索这两个条件之间的潜在相关性.
主要方法:
- 一个56岁妇女的病例报告.
- 审查患者的病史,包括诊断和治疗.
- 对ITP和IgG4-RD治疗疗效的分析.
主要成果:
- 这位患者在2005年被诊断出ITP,并在2011年被诊断出IgG4-RD.
- 针对ITP复发和IgG4-RD,使用了各种治疗方法,反应各异.
- 与普得尼松和mycophenolate的联合治疗显示ITP的部分反应.
结论:
- IgG4-RD 和 ITP 的共存带来了复杂的管理挑战.
- 需要进一步调查以了解IgG4-RD和ITP之间的潜在相关性.
- 患者对免疫抑制剂的反应表明了需要进一步研究的潜在联系.
更多相关视频
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
7.2K
10:35Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
8.2K
相关概念视频
Transcytosis of IgG
2.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
